Because of their intense white lines and large f HH values, lanthanide atoms are of great interest for solving structures of biological macromolecules using single-wavelength anomalous diffraction (SAD) or multiple-wavelength anomalous diffraction (MAD) methods. In this work, a series of seven gadolinium complexes are described which provide excellent derivatives for anomalous diffraction experiments in biological systems. These highly soluble lanthanide complexes can easily be introduced into protein crystals either by soaking or by co-crystallization, without signi®cantly affecting the crystallization conditions, by employing highly concentrated complex solutions (9100 mM). De novo phasing by the SAD method was carried out with several proteins of known as well as previously unknown structures by employing this new class of heavy-atom compounds. Diffraction data were collected either with a laboratory source, making use of the high anomalous signal (f HH = 12 e À ) of gadolinium with Cu K radiation, or with synchrotron radiation at the peak of the gadolinium L III absorption edge, which exhibits a strong white line (! = 1.711 A Ê , f HH = 28 e À ). Using one of these gadolinium complexes, Gd-HPDO3A, the structure of a bacterial chimeric ornithine carbamoyl transferase, OTCase3630, a dodecameric protein of 450 kDa, was determined. Employed with the SAD method, these seven complexes could be of particular interest for high-throughput macromolecular crystallography.
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Introduction
The multiple-wavelength anomalous solvent-contrast (MASC) method (Fourme et al., 1995; Ramin et al., 1999; Shepard et al., 2000) uses the anomalous scattering of a chemical species dispersed at high concentration in the solvent of a crystal of a biological macromolecule in order to determine the molecular envelope of the protein as well as thē uctuations of the electron density at low resolution. The contrast variation is obtained by changing the wavelength of the incident X-rays around one of the absorption edges of the anomalous scatterer.
In contrast to the multiple-wavelength anomalous diffraction (MAD) method, for which the anomalous scatterers need to be well localized, the anomalous partial structure in the MASC method is supposed to correspond to a uniform electron density extending over the whole solvent domain, where the solvent molecules are virtually free. As a consequence, in an ideal MASC experiment the contrast agent should not bind signi®cantly to the protein even at high concentration (9 1 M). From this point of view, ionic compounds are not well suited as MASC agent candidates because they usually bind quite strongly to the protein (Ramin et al., 1999). Indeed, the binding of ionic compounds has been used in cryosoaking methods of preparing heavy-atom derivatives (Dauter et al., 2000) . Sound speci®cations for an ideal MASC contrast agent are therefore (i) it should contain a strong anomalous scatterer, preferably with a white line in the selected absorption edge, (ii) it should be electrically neutral, (iii) it should be water-soluble at high concentration (9 1 M) and (iv) it may be introduced at high concentration into the crystal either by soaking or by co-crystallization without damaging the crystal or disturbing the crystallization conditions.
The electrically neutral gadolinium complex Gd-HPDO3A, which is employed as a contrast agent for magnetic resonance imaging, ful®lled the ®rst three characteristics. It was necessary to verify whether it was possible to introduce it at high concentration into biological macromolecular crystals without signi®cant binding of the complex to the macromolecule. In fact, Gd-HPDO3A turned out to bind strongly to the ®rst tested protein, which was hen egg-white lysozyme (HEWL). The structure of the Gd-HPDO3A derivative of HEWL was easily solved applying the singlewavelength anomalous diffraction (SAD) method to diffraction data collected with a conventional X-ray source (Girard et al., 2002) . Consequently, Gd-HPDO3A looked to be of particular interest as a tool for solving the phase problem in biological macromolecular crystallography. Subsequently, seven gadolinium complexes, including Gd-HPDO3A, have been tested on several proteins and have been found to provide excellent heavyatom derivatives for anomalous diffraction experiments in macromolecular crystallography (Girard et al., 2003) .
A series of gadolinium complexes
The seven gadolinium complexes are composed of ligand molecules (Fig. 1 ion, their carboxylic groups are deprotonated. Therefore, the resulting complexes are neutral except for Gd-DOTA and Gd-DOTMA, which carry a single negative global charge, and Gd-DTPA, which bears a double negative charge. They are all highly soluble in water.
The sources of the seven gadolinium complexes are given by Girard et al. (2003) .
Tests on proteins of known structure
As already mentioned, Gd-HPDO3A, the ®rst tested compound, bound strongly to HEWL (Girard et al., 2002) . Tetragonal gadolinium-derivative crystals of HEWL were obtained by co-crystallization using NaCl as precipitant and different concentrations of the complex. Diffraction data from three derivative crystals (100, 50 and 10 mM Gd-HPDO3A concentrations) were collected to a resolution of 1.7 A Ê using Cu K radiation from a laboratory X-ray generator. In both the 100 and the 50 mM derivatives, two highly occupied Figure 1 The different ligands in the seven Gd complexes presented in this study. DO3A, 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid; DOTA, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; HPDO3A, 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid; DOTMA, a,a H ,a HH ,a HHH -tetramethyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; HPSA-DO3A, 10-(2-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}-1-(hydroxymethyl)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid; DTPA-BMA, diethylenetriaminepentaacetic acid bismethylamide; DTPA, diethylenetriaminepentaacetic acid. Ligands leading to non-charged Gd complexes are on the left-hand side of the ®gure.
binding sites of the gadolinium complex were localized. In the 10 mM derivative, only one site was occupied. With both the 100 and the 50 mM derivatives, SAD phasing using the program OASIS (Hao et al., 2000) followed by density modi®cation with the program DM (Cowtan & Main, 1996) from the CCP4 suite of programs (Collaborative Computational Project, Number 4, 1994) led to electron-density maps of high quality. The structure of the 100 mM Gd-HPDO3A derivative (PDB code 1h87) was re®ned using the program CNS (Bru È nger et al., 1998). The ®nal re®nement residuals R and R free (Bru È nger, 1992) were 18.0 and 20.0%, respectively. The Gd-HPDO3A binding mode was analyzed on the basis of this structure. It combines hydrophobic interactions and hydrogen bonds. The hydrophobic interactions involve tryptophan residues and the tetraazacyclododecane macrocycle of the ligand molecule. On the opposite side of the Gd-HPDO3A complex, pointing toward the solvent, a well structured hydrogen-bonding network involves water molecules (including a water molecule directly bound to the gadolinium), the carboxylic functions of the HPDO3A ligand and protein residues. These interactions, which are rather weak, may explain why high concentrations of the gadolinium complex can be used without signi®cantly modifying the crystallization conditions. It may also explain why concentrated solutions of the gadolinium complex must be used to obtain suf®ciently occupied gadolinium sites. Indeed, the site occupancies increase with increasing concentrations of the gadolinium complex (Girard et al., 2002) . Nevertheless, a lysozyme derivative co-crystallized with 100 mM Gd-HPDO3A that was back-soaked for 8 h in a 10 mM solution of Gd-HPDO3A gave Gd-site occupancies that were very similar to those of a crystal also prepared with 100 mM Gd-HPDO3A that was not backsoaked (Table 1 ). This suggests that once the lysozymederivative crystal has grown, the Gd-HPDO3A complex cannot leave the binding site and diffuse outside the crystal. Conversely, we never succeeded in preparing lysozymederivative crystals by soaking native crystals in Gd-HPDO3A solutions. This behaviour may be quite speci®c to lysozyme, which is characterized by an unusually low solvent content of the native crystals (27%).
Catalase from Proteus mirabilis (PMC) was used as a second test protein with the Gd-HPDO3A complex. PMC is a 55 kDa enzyme of known structure (Gouet et al., 1995; Andre Á oletti et al., 2003) that catalyzes the decomposition of hydrogen peroxide into oxygen. Native crystals were obtained using ammonium sulfate as precipitant at a concentration in the range 2.3±2.7 M. The crystals were then conserved in a solution containing 3.7 M ammonium sulfate. Soaking conditions had to take into account this particularly high salt content. Thanks to the high solubility of the Gd-HPDO3A complex and its availability as a powder, native crystals could be soaked in a solution containing 3.7 M ammonium sulfate and 50 or 100 mM Gd-HPDO3A. A SAD data set was collected at the maximum of f HH in the white line of the Gd L III absorption edge (! = 1.711 A Ê , f HH = 28 e À ) on a 100 mM Gd-HPDO3A derivative of PMC. Initial site positions were found using the program SHELXS97 (Sheldrick, 1990) . Subsequent cycles of heavy-atom site re®nement using the program MLPHARE (Otwinowski, 1991) from the CCP4 suite of programs led to a ®rst set of phases. The initial phases were improved through density modi®cation using the program DM. New sites were detected in the anomalous difference Fourier maps and were introduced into the phasing process. At the end of this procedure, 13 Gd-HPDO3A binding sites were located. Very good phases were obtained with a ®nal ®gure of merit of 0.8. The structure of the Gd-HPDO3A derivative of PMC was re®ned using the program CNS. Although the crystals were soaked for no longer than 10 min, the occupancies of the two main sites were found to be higher than 0.7. A full report will be published elsewhere (E Â . Girard, V. Stojanoff, H. Jouve, J. Vicat & R. Kahn, in preparation), including a comparison between the SAD phasing of data collected at the Gd L III absorption edge and the SAD phasing of data collected with a conventional X-ray source on a Gd-HPDO3A derivative of PMC. To our knowledge, these experiments made PMC the largest protein structure solved directly by the SAD method with Cu K radiation on a derivative crystal.
In order to compare the seven gadolinium complexes for SAD structure determination, studies were carried out on two proteins of known structure. Results on the corresponding derivatives of HEWL and of urate oxidase from Aspergillus avus, a medium-size protein of 295 residues, have been described in a previous paper (Girard et al., 2003) .
Lysozyme-derivative crystals were obtained by co-crystallizing the protein with the seven gadolinium complexes at a concentration of 100 mM using the usual crystallization conditions with NaCl as precipitant. Diffraction data were collected to a resolution of 1.7 A Ê using Cu K radiation from a laboratory X-ray generator. For three lysozyme-derivative crystals containing the complexes Gd-HPDO3A, Gd-DO3A and Gd-DOTA, respectively, SAD phasing led to electrondensity maps of good quality, allowing chain tracing.
Urate oxidase native crystals grew with PEG 8000 as precipitating agent. Derivative crystals were obtained by soaking native crystals in 100 mM solutions of the seven gadolinium complexes. Diffraction data were collected at the maximum of f HH in the white line of the Gd L III absorption edge. Thanks to the large anomalous signal of gadolinium at this wavelength and despite the resolution of the data being Table 1 Occupancies and B factors for the two gadolinium sites of lysozymederivative crystals obtained by co-crystallization with 100 mM Gd-HPDO3A.
The ®rst crystal was back-soaked for 8 h in a 10 mM solution of Gd-HPDO3A. The second crystal was used without back-soaking. The binding modes of the complexes to the proteins in the best derivative crystals of HEWL and of urate oxidase are very different. Whereas Gd-HPDO3A binds to tryptophan residues of HEWL, the binding-site environment of Gd-DTPA-BMA involves charged residues of urate oxidase (Asp141 and Asp133 in the most occupied site, Glu131 and Lys143 in the second site).
The three gadolinium complexes giving the best results with urate oxidase, Gd-DTPA-BMA, Gd-DO3A and Gd-DOTMA, were also tested on VIM-2, a zinc -lactamase of class B from a Pseudomonas aeruginosa clinical isolate (Lauretti et al., 1999) . The structure of this 240-residue protein had already been solved in our laboratory using molecular replacement (I. Garcia-Saez, J.-D. Docquier, G. M. Rossolini, M. Galleni, J.-M.
Fre Á re & O. Dideberg, in preparation). Crystals of the native protein were obtained with 30% PEG 8000 and 200 mM sodium acetate as precipitating agent. Derivative crystals were obtained by soaking the native crystals in 100 mM solutions of the three complexes. Diffraction data were collected at 3.14 A Ê resolution at the Gd L III absorption edge using beamline BM30A at the ESRF (Grenoble, France). Likewise for urate oxidase, the resolution of the diffraction data was limited by the 165 mm diameter of the MARCCD detector located at 132 mm from the sample. Data were processed using the program DENZO (Otwinowski & Minor, 1997) and scaled together using the program SCALA (Collaborative Computational Project, Number 4, 1994). A summary of datacollection parameters and processing statistics is given in Table 2 . The binding of all the complexes to the protein was clearly evidenced by the strong anom-
Girard et al. High-phasing-power lanthanide complexes 1917 CCP4 study weekend Table 2 Data-collection parameters and data processing and phasing statistics for three gadoliniumderivative crystals of zinc -lactamase VIM-2.
Values in parentheses correspond to the highest resolution bin.
Gadolinium complex
Gd 25.0±3.14 (3.31±3.14) 25.0±3.14 (3.31±3.14) 25.0±3.14 (3.31±3.14) alous signal leading to large R ano values, as well as by high peaks in the anomalous Patterson maps (Fig. 2) .
The procedure used to phase the SAD diffraction data from VIM-2 was very similar to the procedure used to phase the urate oxidase data (Girard et al., 2003) . Initial site positions were found using the program SnB (Miller et al., 1994; Weeks & Miller, 1999) . Phasing was carried out by performing subsequent cycles of heavy-atom site re®nement using the program MLPHARE, density modi®cation using the program DM and detection of new sites in the anomalous difference Fourier maps. The resulting experimental electron-density maps were easily interpretable (Fig. 3) . The best results were obtained with the Gd-DTPA-BMA derivative (Table 2) as shown by the large FOM (0.538) obtained before any density modi®cation, the high correlation coef®cient between the experimental electron-density map and the map calculated from the known structure (0.590) and by the overall quality of the experimental electron-density map. The comparison of the results obtained with derivative crystals prepared with the seven gadolinium complexes is in progress.
Solving an unknown structure
We present here a short description of the structure determination of a chimeric ornithine carbamoyl transferase, OTCase 3630, using Gd-HPDO3A for SAD phasing. A full report of this structure determination will be published elsewhere (E Â . Girard, G. Sainz, P. L. Anelli, J. Vicat & R. Kahn, in preparation).
Chimeric OTCase3630 was obtained by intragenic fusion of the gene coding for the catabolic OTCase from P. aeruginosa and of the gene coding for the anabolic OTCase from Escherichia coli (Nguyen et al., 1996) . It is formed by the ®rst 100 amino acids of E. coli OTCase, which is a non-allosteric enzyme, followed by the last 234 residues of the P. aeruginosa OTCase, which presents allosteric properties. OTCase3630 is still allosteric. Previous trials to solve the structure of OTCase3630 by molecular replacement did not give satisfactory results.
Crystals were obtained using ammonium sulfate as precipitating agent. They belong to space group P2 1 . The asymmetric unit contains one dodecamer of 450 kDa.
Preliminary trials using native crystals soaked in 100 mM Gd-HPDO3A solutions allowed the detection of clear binding of the gadolinium complex. Derivative crystals for the ®nal data collection were obtained by co-crystallization with 100 mM Gd-HPDO3A complex added to the native crystallization conditions. The structure was solved using 3 A Ê resolution SAD data collected on co-crystallized derivative crystals at the Gd L III absorption edge using beamline BM14 at the ESRF (Grenoble, France).
The coordinates of 20 sites were determined using the program SnB. Re®nement of coordinates and occupancies of these sites and phasing of the SAD data were performed with the program SHARP (de La Fortelle & Bricogne, 1997) . New gadolinium sites were identi®ed from the residual maps, leading to a ®nal total of 67 detected binding sites and a ®gure of merit of 0.43 before density modi®cation. Solvent¯attening and histogram matching using the program DM led to a ®gure of merit of 0.76 and to a readily interpretable electron-density map.
Phases were extended to higher resolution with diffraction data collected on native crystals to 2.5 A Ê resolution at ! = 0.9797 A Ê using beamline ID14-EH4 at the ESRF (Grenoble, France). An excellent electron-density map with a ®gure of merit of 0.81 was obtained after phase extension using density modi®cation and application of the non-crystallographic symmetry of the dodecamer with the program DM. An atomic model has been built from this electrondensity map using the programs QUANTA (Accelrys Inc.) and O (Jones et al., 1991) . Re®nement of the structure is in progress.
Figure 3
Experimental electron-density maps obtained after DM for the zinc -lactamase derivative crystals of the three studied Gd complexes. (a) Gd-DTPA-BMA, (b) Gd-DO3A, (c) Gd-DOTMA. The represented protein region corresponds to helix H1 (residues 60±75). Maps are contoured at 1'. This ®gure was drawn with the program BOBSCRIPT (Esnouf, 1997).
As can be seen in Fig. 4 , the good quality of the experimental electron-density map obtained directly after density modi®cation of the SAD data using neither the noncrystallographic symmetry information nor data at higher resolution con®rms the high phasing power of the Gd-complex derivative combined with the SAD method. Therefore, such a combination allows the phasing of diffraction data for a protein assembly of 450 kDa.
Discussion
When the anomalous scatterers are chemically identical and their sites are fully occupied, the strength of the anomalous signal can be estimated by the Bijvoet ratio (Hendrickson & Teeter, 1981) ,
where N A is the number of anomalous scatterers with anomalous scattering factor f HH A and where N P is the number of atoms of the protein of mean scattering factor Z eff . More generally, when the crystal contains different anomalous scatterers with different site occupancies this relationship becomes (see Appendix A)
where q j and f HH j are the site occupancy and the imaginary part of the atomic scattering factor of the anomalous scatterer j, respectively.
Identical Bijvoet ratios are therefore obtained for a protein that is four times larger either when f HH j is doubled for each anomalous scatterer and the site occupancies are ®xed or when the site occupancies are doubled and the value of each f HH j is ®xed. In contrast, to obtain identical Bijvoet ratios for a protein that is four times larger with q j and f HH j ®xed, the number of anomalous scatterers must be multiplied by 4. Therefore, with their large f HH values, lanthanide atoms are of special interest for solving macromolecular structures using anomalous scattering. The gadolinium complexes presented in this paper can be introduced into crystals at high concentration without affecting the crystal quality and may bind to the macromolecule giving sites with high occupancies thus providing excellent derivatives for SAD or MAD experiments.
Acta Cryst. Experimental electron-density map of OTCase3630 obtained with phases determined after SHARP and DM, without application of NCS for the 3 A Ê resolution SAD data set. The depicted protein region corresponds to helix H1 (residues 18±37). The map is contoured at 1'.
Since the anomalous scattering of gadolinium is still high with Cu K radiation (f HH = 12 e À ), actual binding of different complexes to the macromolecule in the crystal can be tested using a conventional X-ray source. In case of suf®ciently strong binding, the structure can be solved from a SAD data set collected at this wavelength. High data redundancy may then be necessary to compensate for the weakness of the anomalous signal, which is weaker than would be obtained at the peak in the L III absorption edge (f HH = 28 e À ). From a purely statistical point of view, neglecting other sources of bene®t mainly arising from the geometrical quality of the source when using synchrotron radiation and taking only into account that the precision of a measurement varies with the square root of the number of measurements N, a redundancy multiplied by
should be necessary to compensate for the weaker anomalous signal. Exploiting this series of seven gadolinium complexes, it is possible to obtain a variety of different derivatives. As previously mentioned for the Gd-HPDO3A derivative of HEWL, this gadolinium complex binds to the protein through hydrophobic contacts. It can be seen in Fig. 5 that a similar situation is observed for all tested proteins that gave high Gd-HPDO3A site occupancies, namely HEWL, catalase and OTCase3630. For these three derivatives the most highly occupied binding sites have aromatic residues (tryptophan, tyrosine, phenylalanine) in their direct environment.
Except for HEWL, for which the close crystal packing seems to restrict the location of the possible binding sites, different complexes tend to bind in different locations and consequently in different ways to the protein.
Even if all the complexes are rather large, there is enough room in the solvent channels to allow diffusion of the complex in all the investigated crystals, leading to a number of Gd-binding sites (Table 3) .
This study shows that excellent derivatives can be obtained under various crystallization conditions and that effective binding of the complexes can be achieved even with high concentrations of precipitating agents (PEGs or salts). For a few tested proteins we could not obtain any useful derivative with the presented compounds. Nevertheless, in most cases excellent derivatives were obtained using this series of gadolinium complexes, which makes it a valuable tool for macromolecular crystallography.
